Introduction
Exercise refers to planned, structured, and repetitive physical activities aimed at improving or maintaining health and physical fitness. Beyond enhancing physical fitness, exercise is widely recognized as a highly effective non-pharmacological intervention for preventing chronic diseases and mitigating age-related functional decline (). In metabolic disorders such as type 2 diabetes, exercise enhances insulin sensitivity through GLUT4-mediated glucose uptake, thereby improving blood sugar regulation and reducing complications (). Similarly, for cardiovascular diseases, it strengthens cardiac contractility, improves vascular endothelial function, and optimizes lipid profiles, which in turn lowers the incidence of atherosclerosis and myocardial infarction (). Moreover, in neurodegenerative conditions like Alzheimer’s disease, exercise upregulates neurotrophic factors and accelerates β-amyloid clearance, thus safeguarding cognitive function (). Additionally, in chronic inflammatory diseases such as rheumatoid arthritis, it modulates immune responses by reducing pro-inflammatory cytokines and promoting anti-inflammatory macrophage polarization, thereby alleviating symptom severity (). Critically, the development and progression of these diseases are closely intertwined with the aging process: aging elevates the risk of their onset, while disease progression in turn exacerbates age-related functional decline. Thus, exercise holds significant importance in anti-aging.
The anti-aging effects of exercise are mediated through multiple interconnected biological mechanisms (; ). Firstly, exercise enhances mitochondrial function via AMPK/PGC-1α activation, boosting biosynthesis efficiency and oxidative phosphorylation capacity while increasing ATP production and suppressing reactive oxygen species accumulation (; ). Secondly, exercise exerts anti-inflammatory and immunomodulatory effects by reducing proinflammatory cytokines (IL-6, TNF-α), promoting M2 macrophage polarization, and enhancing regulatory T cell function (; ). Thirdly, exercise provides neuroprotection through upregulated neurotrophic factors (BDNF, IGF-1), improved cerebral perfusion, and accelerated β-amyloid clearance (; ). Finally, exercise maintains metabolic homeostasis via GLUT4-mediated glucose uptake, IRS1/PI3K/AKT-dependent insulin sensitivity enhancement, and AMPK-coordinated lipid metabolism (; ; ) (Figure 1). Despite these multifaceted benefits, elderly individuals often struggle to maintain exercise due to physical decline, comorbidities, or environmental constraints. This limitation underscores the need for exercise-mimetic interventions to harness the anti-aging benefits of physical activity.
FIGURE 1
Recently, Geng et al. identified the renal metabolite betaine as a potent exercise mimetic through comprehensive multi-omics analysis of exercise responses, offering a promising solution for individuals unable to sustain long-term exercise (). Specifically, through multi-omics analysis of 13 healthy males, Geng et al. systematically characterized the differential responses to Acute exercise (AE) and Long-term exercise (LE). AE primarily induced acute metabolic and immune stress, marked by significant increases in non-esterified fatty acids, decreased total bile acids, and upregulation of inflammatory factors including IL-6 and EN-RAGE, alongside activation of the glucocorticoid receptor pathway and enhanced anaerobic glycolysis. In contrast, LE triggered sustained adaptations involving metabolic reorganization, immune remodeling, and gut microbiota restructuring. Metabolic reorganization is achieved through the coupling of fatty acid oxidation with tricarboxylic acid cycle activity, accompanied by optimized amino acid metabolism and activated antioxidant defenses. Immune remodeling is reflected by increased naive lymphocytes, reduced neutrophils, and attenuated lymphocyte aging via ETS1 downregulation. Gut microbiota restructuring is characterized by a decrease in opportunistic pathogens and suppressed lipopolysaccharide biosynthesis. Critically, LE also specifically activated methionine metabolism pathways, inducing significant enrichment of the renal metabolite betaine.
Integrated multi-omics analysis confirmed the kidney as the central organ for exercise-induced betaine metabolism, mediated by upregulation of renal choline dehydrogenase (CHDH). Mechanistic studies demonstrated betaine directly binds and inhibits the innate immune kinase TBK1, reducing lipopolysaccharide-induced release of pro-inflammatory cytokines TNF-α and IL-6 while inhibiting immune cell adhesion. Murine models further established betaine’s capacity to alleviate cellular senescence, consistently reducing established aging markers including SA-β-Gal and p21. These data reveal the kidney-betaine-TBK1 axis as the core pathway coordinating exercise-mediated anti-inflammatory and anti-senescence effects (Figure 2).
FIGURE 2
To validate the therapeutic efficacy of betaine, Geng et al. conducted comprehensive supplementation studies in aged murine models. They supplemented aged mice with 1% betaine daily for 8 weeks and found that betaine concentrations in the kidneys of aged mice increased to levels comparable to those induced by LE. Functional evaluation showed that aged mice had significantly improved motor coordination, muscle strength and spatial memory ability, and significantly reduced depression-like behaviors. Histopathological analysis revealed attenuated markers of aging, reduced lipid deposition, and reduced fibrosis in the kidney, liver, lung, and skin, along with restoration of skeletal muscle morphology and epidermal architecture. Molecular analysis confirmed that betaine could inhibit the phosphorylation of TBK1/IRF3/p65 signaling pathway, down-regulate the proinflammatory cytokines TNF-α and IL-1β, and activate AMPK/SIRT1/PGC-1α signaling pathway. These collective findings support betaine as a viable exercise-mimetic intervention for counteracting age-related physiological and functional decline.
However, we recognize that this study has certain limitations. The human cohort comprised only 13 healthy young males, representing both a small sample size and the exclusion of female participants. Preclinical validation was similarly restricted to aged male murine models. This male-exclusive design restricts generalizability to females, particularly given documented sex differences in hormonal regulation, betaine metabolic kinetics, and female-specific aging processes. Crucially, betaine’s metabolism in female physiology and its impact on reproductive systems remain uncharacterized. We therefore emphasize the necessity for expanded investigations with balanced gender representation and larger cohorts to comprehensively evaluate betaine’s effects across diverse populations.
We propose that betaine’s most immediate translational value lies in overcoming exercise adherence barriers in elderly populations. Although regular exercise significantly delays aging, elderly individuals frequently struggle with sustained physical activity due to age-related physical decline, comorbidities, or environmental constraints (). Betaine recapitulates exercise-mediated protection against multisystem aging: preserving neurocognitive function by suppressing microglial overactivation, combating sarcopenia through increased muscle fiber cross-sectional area, and reducing metabolic disease risk via improved glucose-lipid homeostasis (). To advance clinical implementation, we recommend prioritizing long-term safety assessments and dose-response validation in elderly cohorts, coupled with exploration of synergistic formulations combining betaine with senolytic agents. These initiatives constitute our strategy to establish betaine as a viable non-pharmacological alternative for healthy aging promotion.
At the same time, we believe that betaine can be used as a fundamental candidate for ovarian aging intervention research. Ovarian aging constitutes a core manifestation of declining female reproductive and endocrine function, characterized by diminished follicular reserve, granulosa cell senescence, and chronic inflammatory microenvironments (). Aberrant TBK1/NF-κB signaling accelerates ovarian aging by promoting follicular atresia and granulosa cell apoptosis (; ). Given betaine’s specific inhibition of TBK1-mediated pro-inflammatory cascades, we propose investigating its capacity to mitigate ovarian inflammation and reduce senescence markers in granulosa cells. Subsequent development of betaine-based therapeutics could provide targeted alternatives to traditional hormone replacement for premature ovarian insufficiency and menopausal syndrome, potentially circumventing estrogen-associated comorbidities while restoring endocrine homeostasis.
Statements
Author contributions
YL: Writing – original draft. JL: Writing – review and editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Key Program of Guangxi Natural Science Foundation (Grant No. 2025GXNSFDA069048), the Innovation Project of Guangxi Graduate Education of Guangxi University of Chinese Medicine (Grant No. YCSY2025001), the Guangxi Interdisciplinary Innovation Team of Chinese Medicine (Grant No. GZKJ2302), the Guangxi First-class Discipline of Chinese Medicine (Grant No. Gui Textbook Research [2022] No. 1), the Huang Danian-Type Teacher Team of National Universities–Teacher Team of Basic Courses of Chinese and Western Medicine (Grant No. Ministry of Education Teacher Letter [2022] No. 2), and the Guangxi Famous Chinese Medicine JL Inheritance Studio (Grant No. Gui TCM Science and Education Development [2021] No. 6).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
CarteeG. D.HeppleR. T.BammanM. M.ZierathJ. R. (2016). Exercise promotes healthy aging of skeletal muscle. Cell. Metab.23 (6), 1034–1047. 10.1016/j.cmet.2016.05.007
2
CavalcanteM. B.SampaioO. G. M.CamaraF. E. A.SchneiderA.de AvilaB. M.ProsczekJ.et al (2023). Ovarian aging in humans: potential strategies for extending reproductive lifespan. Geroscience45 (4), 2121–2133. 10.1007/s11357-023-00768-8
3
CotmanC. W.BerchtoldN. C.ChristieL. A. (2007). Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci.30 (9), 464–472. 10.1016/j.tins.2007.06.011
4
De la RosaA.Olaso-GonzalezG.Arc-ChagnaudC.MillanF.Salvador-PascualA.Garcia-LucergaC.et al (2020). Physical exercise in the prevention and treatment of alzheimer's disease. J. Sport Health Sci.9 (5), 394–404. 10.1016/j.jshs.2020.01.004
5
FranceschiC.GaragnaniP.PariniP.GiulianiC.SantoroA. (2018). Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol.14 (10), 576–590. 10.1038/s41574-018-0059-4
6
GengL.PingJ.WuR.YanH.ZhangH.ZhuangY.et al (2025). Systematic profiling reveals betaine as an exercise mimetic for geroprotection. Cell. 10.1016/j.cell.2025.07.030
7
HoodD. A.UguccioniG.VainshteinA.D'SouzaD. (2011). Mechanisms of exercise-induced mitochondrial biogenesis in skeletal muscle: implications for health and disease. Compr. Physiol.1 (3), 1119–1134. 10.1002/cphy.c100074
8
LehnigA. C.StanfordK. I. (2018). Exercise-induced adaptations to white and brown adipose tissue. J. Exp. Biol.221 (Pt Suppl. 1), jeb161570. 10.1242/jeb.161570
9
LiZ.WangX. Q. (2022). Clinical effect and biological mechanism of exercise for rheumatoid arthritis: a mini review. Front. Immunol.13, 1089621. 10.3389/fimmu.2022.1089621
10
Lopez-OtinC.BlascoM. A.PartridgeL.SerranoM.KroemerG. (2023). Hallmarks of aging: an expanding universe. Cell.186 (2), 243–278. 10.1016/j.cell.2022.11.001
11
LuX.ChenY.ShiY.ShiY.SuX.ChenP.et al (2025). Exercise and exerkines: mechanisms and roles in anti-aging and disease prevention. Exp. Gerontol.200, 112685. 10.1016/j.exger.2025.112685
12
MagkosF.HjorthM. F.AstrupA. (2020). Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol.16 (10), 545–555. 10.1038/s41574-020-0381-5
13
MoraJ. C.ValenciaW. M. (2018). Exercise and older adults. Clin. Geriatr. Med.34 (1), 145–162. 10.1016/j.cger.2017.08.007
14
PangrazziL.MerykA. (2024). Molecular and cellular mechanisms of immunosenescence: modulation through interventions and lifestyle changes. Biol. (Basel).14 (1), 17. 10.3390/biology14010017
15
RichterE. A.HargreavesM. (2013). Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol. Rev.93 (3), 993–1017. 10.1152/physrev.00038.2012
16
StanfordK. I.GoodyearL. J. (2016). Exercise regulation of adipose tissue. Adipocyte5 (2), 153–162. 10.1080/21623945.2016.1191307
17
TuckerW. J.Fegers-WustrowI.HalleM.HaykowskyM. J.ChungE. H.KovacicJ. C. (2022). Exercise for primary and secondary prevention of cardiovascular disease: JACC focus seminar 1/4. J. Am. Coll. Cardiol.80 (11), 1091–1106. 10.1016/j.jacc.2022.07.004
18
van der PloegH. P.BullF. C. (2020). Invest in physical activity to protect and promote health: the 2020 WHO guidelines on physical activity and sedentary behaviour. Int. J. Behav. Nutr. Phys. Act.17 (1), 145. 10.1186/s12966-020-01051-1
19
VossM. W.NagamatsuL. S.Liu-AmbroseT.KramerA. F. (1985)2011). Exercise, brain, and cognition across the life span. J. Appl. Physiol.111 (5), 1505–1513. 10.1152/japplphysiol.00210.2011
20
ZhangJ.ChenY.ChenX.ZhangW.ZhaoL.WengL.et al (2021). Deubiquitinase USP35 restrains STING-Mediated interferon signaling in ovarian cancer. Cell. Death Differ.28 (1), 139–155. 10.1038/s41418-020-0588-y
Summary
Keywords
exercise, betaine, TBK1, inflammation, aging
Citation
Liu Y and Lin J (2025) Betaine: a promising novel anti-aging substance as an exercise mimetic. Front. Pharmacol. 16:1672934. doi: 10.3389/fphar.2025.1672934
Received
25 July 2025
Accepted
18 August 2025
Published
28 August 2025
Volume
16 - 2025
Edited by
Ryan Varghese, Saint Joseph’s University, United States
Reviewed by
Krishil Oswal, Bharati Vidyapeeth Deemed University, India
Pooja Tiwary, Bharati Vidyapeeth Deemed University, India
Updates
Copyright
© 2025 Liu and Lin.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiang Lin, linj@gxtcmu.edu.cn
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.